| 英文别名 |
6-Amino-4-(4-phenoxyphenylethylamino)quinazoline;QNZ (EVP4593);4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine;EVP4593;EVP-4593;QNZ;NF-kappaB Activation Inhibitor;N4-[2-(4-Phenoxyphenyl)ethyl]-4,6-quinazolinediamine;N4-(4-phenoxyphenethyl)quinazoline-4,6-diamine;InSolution™ NF-kappaB Activation Inhibitor;C22H20N4O;EVP 4593;Curator_000005;NF-kB activation inhibitor;6-amino-4-(4-phenoxyphenylethylamino) quinazoline;QNZ(EVP45;MFCD06411436;HMS3402B14;CHEMBL522502;4,6-Quinazolinediamine, N4-[2-(4-phenoxyphenyl)ethyl]-;SR-01000946744-1;N~4~-[2-(4-Phenoxyphenyl)ethyl]quinazoline-4,6-diamine;HMS3652J12;HMS3886M05;HMS3674K05;CU-00000000003-1;SR-01000946744;AC-32085;AMY24212;F17390;545380-34-5;AG-F-89549;HMS3649N20;DA-42127;HMS3748A11;QNZ(EVP4593)?;DTXSID00333507;QNZ(EVP4593);EX-A182;EVP4593, >=98% (HPLC);s4902;N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine;CAY10470;SCHEMBL157421;CS-1515;Q27087912;BCP07901;N4-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine;Q0109;AS-67689;5?-Dihydro Testosterone Undecanoate;CCG-206870;SW220245-1;HMS3229K22;GTPL6012;HY-13812;AKOS022175523;SDCCGSBI-0086776.P003;BRD-K68395654-001-05-6;BRD-K68395654-001-06-4;BRD-K68395654-001-03-1;4-N-[2-(4-Phenoxyphenyl)ethyl]quinazoline-4,6-diamine |